Enlivex Therapeutics Ltd. (ENLV) vs Enveric Biosciences, Inc. (ENVB)
A side-by-side comparison of Enlivex Therapeutics Ltd. and Enveric Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ENLV
Enlivex Therapeutics Ltd.
$0.36HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
ENVB
Enveric Biosciences, Inc.
$1.51HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ENLV vs ENVB
growth of $100 · dividends reinvested · last 10yENLV -99.0% (-37.0%/yr)ENVB -100.0% (-75.0%/yr)ENLV compounded faster over this window
Log scale — wide-divergence pair
ENLV ENVB
ENLV vs ENVB: by the numbers
- •ENVB is the larger company ($7M vs $6M market cap).
Metrics side by side
Valuation
| Metric | ENLV | ENVB |
|---|---|---|
| P/E ratio | 0.00 | N/A |
| P/B ratio | 0.00 | 0.84 |
Profitability
| Metric | ENLV | ENVB |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | 105.35% | -108.00% |
| ROIC | -0.32% | -107.99% |
Growth (annualized)
| Metric | ENLV | ENVB |
|---|---|---|
| Total return CAGR (5Y) | -69.81% | N/A |
Go deeper
Dig into the metrics
Enlivex Therapeutics ROEEnveric Biosciences ROEEnlivex Therapeutics operating marginEnveric Biosciences operating marginEnlivex Therapeutics revenue growthEnveric Biosciences revenue growthEnlivex Therapeutics free cash flowEnveric Biosciences free cash flow
Enlivex Therapeutics & Enveric Biosciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.